Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris
Status:
Withdrawn
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
This is a 6 week study to characterize the safety, tolerability and effects of PF-05175157
administered for 6 weeks in subjects with moderate to severe acne vulgaris.